SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-23-000068
Filing Date
2023-05-09
Accepted
2023-05-09 16:07:05
Documents
16
Period of Report
2023-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20230508.htm   iXBRL 8-K 49076
2 EX-99.1 q12023eolsex991.htm EX-99.1 166086
3 EX-99.2 q12023eolsex992.htm EX-99.2 34643
7 imagea.jpg GRAPHIC 10269
8 imageb.jpg GRAPHIC 10269
  Complete submission text file 0001570562-23-000068.txt   448863

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20230508.xsd EX-101.SCH 1909
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20230508_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20230508_pre.xml EX-101.PRE 13051
10 EXTRACTED XBRL INSTANCE DOCUMENT eols-20230508_htm.xml XML 11082
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 23901952
SIC: 2834 Pharmaceutical Preparations